EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Viral Infections and Incidence of Reactivations in Chronic Myeloid Leukemia Patients

Mahmood B Aldapt, Abdulrahman F Al-Mashdali, Khaldun Obeidat, Prem Chandra, Mohamed Yassin

Oncology · 2024

DOI: 10.1159/000534266 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oncology, 2024. Verfasst von Mahmood B Aldapt und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Unity Hospital, Rochester Regional Health, New York, New York, USA. Hauptthemen laut MEDLINE: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Virus Diseases, Hepatitis B. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Viral infections remain a significant problem for patients with chronic myeloid leukemia (CML) who undergo stem cell transplants (SCTs). These infections often result from the reactivation of latent viruses. However, our understanding of the risk of viral reactivation in CML patients who have not undergone SCT is limited, and there is a scarcity of data on this topic. Tyrosine kinase inhibitors (TKIs) have revolutionized the treatment of CML as it is highly successful and has transformed the prognosis of patients with CML. However, TKI may be associated with an increased risk of infections. Summary: We have performed a literature search for publications related to viral infections and their reactivations in patients with CML using PubMed, Scopus, and Google Scholar for the period 2001–2022. The population consisted of patients over 18 years old with a diagnosis of CML and no history of bone marrow transplantation. In an analysis of 41 patients, with 25 males and 16 females, M:F ratio of 1.56:1, and a median age of 50. Age ranged from 22 to 79 years. Most patients with reported viral infections or reactivations were in the chronic phase (CP) of CML, with 22 patients (76%) in the CP, 6 patients (21%) in the accelerated phase, and 1 patient (3%) in the blast phase. Most cases with reported outcomes responded to treatment for CML; only one had refractory disease and 8 cases (32%) had major molecular response. Imatinib was the most used TKI in 31 patients (77%). The most reported viral reactivations were herpes zoster in 17 cases (41%), followed by hepatitis B reactivation in 15 cases (37%). Key Messages: This review sheds light on the importance of having a hepatitis B serology checked before starting TKI therapy and close monitoring for viral infections and reactivations in patients with CML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveVirus DiseasesHepatitis BMaleFemaleHumansYoung AdultAdultMiddle AgedAgedAdolescentIncidenceProtein Kinase Inhibitors

Stichwörter der Autor:innen

Chronic myeloid leukemiaReactivationTyrosine kinase inhibitorViral infections

Substanzen

Protein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Medicine, Unity Hospital, Rochester Regional Health, New York, New York, USA.
  • Department of Medical Oncology/Hematology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
  • Department of Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois, USA.
  • Medical Research Center, Hamad Medical Corporation, Doha, Qatar.

Zitieren

APA

Aldapt, M. B., Al-Mashdali, A. F., Obeidat, K., Chandra, P., & Yassin, M. (2024). Viral Infections and Incidence of Reactivations in Chronic Myeloid Leukemia Patients. Oncology. https://doi.org/10.1159/000534266

Vancouver

Aldapt MB, Al-Mashdali AF, Obeidat K, Chandra P, Yassin M. Viral Infections and Incidence of Reactivations in Chronic Myeloid Leukemia Patients. Oncology. 2024. doi:10.1159/000534266

BibTeX
@article{Aldapt2024,
  author = {Aldapt, Mahmood B and Al-Mashdali, Abdulrahman F and Obeidat, Khaldun and Chandra, Prem and Yassin, Mohamed},
  title = {Viral Infections and Incidence of Reactivations in Chronic Myeloid Leukemia Patients},
  journal = {Oncology},
  year = {2024},
  doi = {10.1159/000534266}
}
Kostenlos starten →